{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:06:10Z","timestamp":1793160370775,"version":"4.5.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1097\/rhu.0b013e31817a7e30","type":"journal-article","created":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T03:10:47Z","timestamp":1222830647000},"page":"267-272","source":"Crossref","is-referenced-by-count":67,"title":["Prophylactic Antibiotic Usage for Pneumocystis jirovecii Pneumonia in Patients With Systemic Lupus Erythematosus on Cyclophosphamide"],"prefix":"10.1097","volume":"14","author":[{"given":"Deepak","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Zachariah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Roppelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarat M.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry L.","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210207","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa043731","article-title":"Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.","volume":"353","author":"Ginzler","year":"2005","journal-title":"N Eng J Med"},{"key":"R2-4-20210207","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1056\/NEJMoa031855","article-title":"Sequential therapies for proliferative lupus nephritis.","volume":"350","author":"Contreras","year":"2004","journal-title":"N Eng J Med"},{"key":"R3-4-20210207","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/096120339200100607","article-title":"Pneumocystis carinii pneumonia in patients with systemic lupus erythematosus.","volume":"1","author":"Liam","year":"1992","journal-title":"Lupus"},{"key":"R4-4-20210207","first-page":"169","article-title":"Pneumocystis carinii pneumonia in a patient with active untreated systemic lupus erythematosus.","volume":"43","author":"Sharma","year":"2001","journal-title":"Indian J Chest Dis Allied Sci"},{"key":"R5-4-20210207","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/00002281-200309000-00002","article-title":"Infectious complications in SLE after immunosuppressive therapies.","volume":"15","author":"Kang","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"R6-4-20210207","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/art.1780390906","article-title":"Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus.","volume":"39","author":"Pryor","year":"1996","journal-title":"Arthritis Rheum"},{"key":"R7-4-20210207","first-page":"246","article-title":"Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases.","volume":"21","author":"Godeau","year":"1994","journal-title":"J Rheumatol"},{"key":"R8-4-20210207","first-page":"1186","article-title":"Risk factors for Pneumocystis carinii pneumonia in patients with polymyositis\/dermatomyositis or systemic lupus erythematosus.","volume":"23","author":"Kadoya","year":"1996","journal-title":"J Rheumatol"},{"key":"R9-4-20210207","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/ard.56.8.481","article-title":"Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide.","volume":"56","author":"Martin-Suarez","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"R10-4-20210207","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/1529-0131(199904)42:4<780::AID-ANR23>3.0.CO;2-M","article-title":"Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality.","volume":"42","author":"Ward","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R11-4-20210207","first-page":"539","article-title":"Causes of death in Korean patients with systemic lupus erythematosus: a single center retrospective study.","volume":"17","author":"Kim","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"R12-4-20210207","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/rheumatology\/39.4.399","article-title":"A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population.","volume":"39","author":"Mok","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"R13-4-20210207","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1136\/ard.60.12.1141","article-title":"Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus.","volume":"60","author":"Noel","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"R14-4-20210207","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1191\/0961203302lu170oa","article-title":"The nature and outcome of infection in systemic lupus erythematosus.","volume":"11","author":"Gladman","year":"2002","journal-title":"Lupus"},{"key":"R15-4-20210207","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/art.10461","article-title":"Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.","volume":"46","author":"Houssiau","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R16-4-20210207","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1191\/0961203302lu243oa","article-title":"Low-dose pulse methylprednisolone for systemic lupus erythematosus flares is efficacious and has a decreased risk of infectious complications.","volume":"11","author":"Badsha","year":"2002","journal-title":"Lupus"},{"key":"R17-4-20210207","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/ard.2004.025528","article-title":"Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus.","volume":"64","author":"Barile-Fabris","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R18-4-20210207","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.amjmed.2005.08.045","article-title":"Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide.","volume":"119","author":"Mok","year":"2006","journal-title":"Am J Med"},{"key":"R19-4-20210207","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/01.rhu.0000221794.24431.36","article-title":"Pneumocystis carinii pneumonia in patients with connective tissue disease.","volume":"12","author":"Li","year":"2006","journal-title":"J Clin Rheumatol"},{"key":"R20-4-20210207","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1177\/0961203306071919","article-title":"Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients.","volume":"15","author":"Bosch","year":"2006","journal-title":"Lupus"},{"key":"R21-4-20210207","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/art.1780210107","article-title":"Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus.","volume":"21","author":"Ginzler","year":"1978","journal-title":"Arthritis Rheum"},{"key":"R22-4-20210207","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00005792-198709000-00002","article-title":"Fatal infections in systemic lupus erythematosus: the role of opportunistic organisms.","volume":"66","author":"Hellmann","year":"1987","journal-title":"Medicine (Baltimore)"},{"key":"R23-4-20210207","first-page":"1191","article-title":"Patients with systemic lupus erythematosus at risk for Pneumocystis carinii pneumonia.","volume":"19","author":"Porges","year":"1992","journal-title":"J Rheumatol"},{"key":"R24-4-20210207","first-page":"480","article-title":"Frequency of adverse drug reactions in patients with systemic lupus erythematosus.","volume":"30","author":"Pope","year":"2003","journal-title":"J Rheumatol"},{"key":"R25-4-20210207","first-page":"265","article-title":"Antibiotic allergy in systemic lupus erythematosus: a case control study.","volume":"19","author":"Petri","year":"1992","journal-title":"J Rheumatol"},{"key":"R26-4-20210207","first-page":"80","article-title":"Trimethoprim-sulfamethoxazole induced aseptic meningitis in a renal transplant patient.","volume":"55","author":"Muller","year":"2001","journal-title":"Clin Nephrol"},{"key":"R27-4-20210207","first-page":"800","article-title":"Trimethoprim-sulfamethoxasole induced meningitis in systemic lupus erythematosus.","volume":"19","author":"Escalante","year":"1992","journal-title":"J Rheumatol"},{"key":"R28-4-20210207","doi-asserted-by":"crossref","first-page":"R23","DOI":"10.1186\/ar2134","article-title":"Association of the diplotype configuration at the N-acetyltransferase 2 gene with adverse events with co-trimoxazole in Japanese patients with systemic lupus erythematosus.","volume":"9","author":"Soejima","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"R29-4-20210207","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2165\/00002018-199512040-00008","article-title":"Drug-induced lupus.","volume":"12","author":"Price","year":"1995","journal-title":"Drug Saf"},{"key":"R30-4-20210207","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1136\/ard.2007.071530","article-title":"International survey on the diagnosis and management of gout.","volume":"66","author":"Doherty","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R31-4-20210207","first-page":"35","article-title":"Perceptions of pediatric primary care physicians on congenital hearing loss and cochlear implantation.","volume":"47","author":"Carron","year":"2006","journal-title":"J Miss State Med Assoc"},{"key":"R32-4-20210207","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMra032588","article-title":"Pneumocystis pneumonia.","volume":"350","author":"Thomas","year":"2004","journal-title":"N Eng J Med"}],"container-title":["JCR: Journal of Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00124743-200810000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:12:59Z","timestamp":1786036379000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00124743-200810000-00004"}},"subtitle":["A Survey of US Rheumatologists and the Review of Literature"],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/rhu.0b013e31817a7e30","relation":{},"ISSN":["1076-1608"],"issn-type":[{"value":"1076-1608","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}